Zobrazeno 1 - 10
of 62
pro vyhledávání: '"K O, Fagerström"'
Autor:
K. O. Fagerström, C. A. Jiménez-Ruiz
Publikováno v:
European Respiratory Review, Vol 17, Iss 110, Pp 192-198 (2008)
There are currently three licensed therapies for smoking cessation: nicotine replacement (NR), bupropion and varenicline. NR can be indicated for: 1) aid in abrupt cessation; 2) gradual reduction in order to quit smoking; 3) temporary abstinence; and
Externí odkaz:
https://doaj.org/article/c240b88bca544c3cb4ed85208cb93c61
Aiding reduction of smoking with nicotine replacement medications: hope for the recalcitrant smoker?
Publikováno v:
Tobacco Control. 6:311-316
OBJECTIVE: To assess the effect of the various nicotine replacement therapies (NRT) on smoking reduction. DESIGN: During an initial sampling week, the subjects familiarised themselves with nicotine gum, patch, nasal spray, vaporiser (vapour inhaler)
Publikováno v:
Journal of Internal Medicine. 240:189-194
OBJECTIVES: To investigate the effects on serum lipids, plasma fibrinogen, plasma insulin, plasma C-peptide and blood glucose, of smoking cessation after 4 months. To develop a group-based smoking intervention programme in primary health care. SETTIN
Autor:
K O, Fagerström
Publikováno v:
Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace. 56(2)
This paper describes assessments that can be useful when giving smokers help to stop. The assessments discussed are: motivation, amount smoked, dependence, lung function, carbon monoxide (CO), earlier cessation experience, knowledge of nicotine's rol
Autor:
K O, Fagerström
Publikováno v:
Italian heart journal : official journal of the Italian Federation of Cardiology. 2
Autor:
K O, Fagerström
Publikováno v:
Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace. 54(6)
Autor:
C A, Jiménez Ruiz, K O, Fagerström
Publikováno v:
Archivos de bronconeumologia. 35(5)
Autor:
K O, Fagerström
Publikováno v:
Wiener klinische Wochenschrift. 110(23)
Publikováno v:
Chest. 108(2)
The effectiveness of nicotine gum in combination with a behavior modification program was studied. The nicotine dependence of participating smokers (N = 322) was assessed. One hundred sixty-eight smokers were labeled as high nicotine dependent and 15
Publikováno v:
European Journal of Clinical Pharmacology.
Fifteen subjects participated in a randomised, placebo-controlled cross-over study to assess the effect of a nicotine vapour inhaler on craving and other withdrawal symptoms during a two-day smoking-free period. Craving and withdrawal symptoms were r